Medizinisches Zentrum Fuer Haematologie Und Onkologie Muenchen MVZ GmbH
- Address
- Winthirstrasse 7, Neuhausen-Nymphenburg, 80639 Munich, Germany
Medizinisches Zentrum Fuer Haematologie Und Onkologie Muenchen MVZ GmbH
The Medizinisches Zentrum Fuer Haematologie Und Onkologie Muenchen MVZ GmbH is a specialized medical research center dedicated to advancing treatments in hematology and oncology. The center demonstrates particular expertise in conducting complex Phase III clinical trials, focusing on personalized and targeted therapy approaches for both solid tumors and hematological malignancies.
- Advanced breast cancer research, including HER2-positive and hormone receptor-positive subtypes with personalized adjuvant therapy strategies
- Multiple myeloma treatment development, including novel combination therapies and autologous stem cell transplantation protocols
- Precision medicine approaches utilizing biomarker-driven patient selection and minimal residual disease monitoring
The center's research portfolio reflects a commitment to innovative combination therapies and evidence-based treatment optimization. Their involvement in multi-arm comparative studies demonstrates expertise in evaluating next-generation antibody-drug conjugates, CDK4/6 inhibitors, and immunomodulatory agents. The center's focus on disease-free survival outcomes and MRD-negative responses underscores their dedication to achieving deep, durable responses that translate into meaningful clinical benefits for patients with cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medizinisches Zentrum Fuer Haematologie Und Onkologie Muenchen MVZ GmbH
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Multicenter Randomized Study of Trastuzumab Deruxtecan vs. Trastuzumab Emtansine in High-Risk HER2-Positive Breast Cancer with Residual Disease | Daiichi Sankyo Inc. | Phase III | Not Recruiting | Apr 2021 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abemaciclib | 1 | Unknown | 2020-07-23 | 2020-07-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.